Ginkgo is so often misspelt as gingko (including by me) that the Oxford English Dictionary now accepts the spelling variation. According to the Oxford Companion to Food, “Ginkgo biloba is the sole ...

Drug developers face rising costs and longer timelines. AI is positioned to reduce both but is hindered in part by incomplete or siloed datasets, which limits their effectiveness for training AI.

BOSTON - Ginkgo Bioworks (NYSE:DNA), a biotech company whose stock has surged over 54% in the past year according to InvestingPro data, announced Wednesday a new strategic partnership with Inductive ...

BOSTON - Ginkgo Bioworks (NYSE:DNA), a biotechnology company with a market capitalization of $659 million and an impressive gross profit margin of 79%, has appointed Brian O’Sullivan as Head of ...

BOSTON, July 17, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the launch of a powerful new capability ...

Joshua Keating is a senior correspondent at Vox covering foreign policy and world news with a focus on the future of international conflict. He is the author of the 2018 book, Invisible Countries: ...

History wasn’t my favorite course in high school, and that was despite having an amazing teacher. Fifty years later I am uncovering a new appreciation for history. Case in point is my fondness for ...

Many of today's most popular Western supplements, medicines and practices can trace their roots back to ancient Eastern medicine. These include practices aimed at tapping into a life force known as Qi ...

Ginkgo Bioworks' restructuring has resulted in a dramatic reduction in cash burn in recent quarters. Ginkgo remains a long way from breakeven though and growth is expected to be poor in 2025. Unless ...

There’s plenty of empty lab space around Greater Boston these days and a lot of competition for life-science tenants. Now Ginkgo Bioworks is throwing some space in the Seaport it doesn’t need at the ...

Ginkgo Bioworks Holdings Inc. has canceled its planned move into the 250,000-square-foot lab data center it’s been building next to its current headquarters on the South Boston waterfront amid cost ...

Virica Biotech will provide a panel of their cell enhancers for use in high-throughput AAV production screening for Ginkgo’s clients. Ginkgo Bioworks will leverage their advanced screening platform ...